Showing results (41-50 of 75) with videos related to
Sort By:
Pageof 8
Clinical Neurology and Neurosurgery|July 15, 2010
Radiation induced early necrosis in patients with malignant gliomas receiving temozolomideEmel Yaman, Suleyman Buyukberber, Mustafa Benekli, et al.Tumori|December 12, 2013
Efficacy and safety of concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced nasopharyngeal cancersMeltem Baykara, Suleyman Buyukberber, Banu Ozturk, et al.Asian Pacific Journal of Cancer Prevention : APJCP|June 4, 2013
Efficacy and safety of concomitant chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced squamous cell head and neck cancersMeltem Baykara, Suleyman Buyukberber, Banu Ozturk, et al.Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|December 9, 2008
Gemcitabine-induced acute coronary syndrome: a case reportBanu Ozturk, Gulten Tacoy, Ugur Coskun, et al.Journal of Cancer Research and Clinical Oncology|February 16, 2010
The effect of bevacizumab on serum soluble FAS/FASL and TRAIL and its receptors (DR4 and DR5) in metastatic colorectal cancerRamazan Yildiz, Mustafa Benekli, Suleyman Buyukberber, et al.Cureus|November 11, 2024
Pan-Immune-Inflammation Value as a Novel Prognostic Biomarker for Advanced Pancreatic CancerAsim Armagan Aydin, Erkan Kayikcioglu, Ahmet Unlu, et al.Medical Oncology (Northwood, London, England)|May 20, 2008
Single agent gemcitabine in the second-line treatment of advanced non-small cell lung cancer after treatment with taxane + platinum regimensUgur Coskun, Ali Osman Kaya, Süleyman Buyukberber, et al.Asian Pacific Journal of Cancer Prevention : APJCP|March 7, 2015
Efficacy of dose dense doxorubicin and cyclophosphamide followed by paclitaxel versus conventional dose doxorubicin, cyclophosphamide followed by paclitaxel or docetaxel in patients with node-positive breast cancerDogan Yazilitas, Mehmet Ali Nahit Sendur, Halit Karaca, et al.Expert Review of Anticancer Therapy|August 29, 2025
The Gustave Roussy immune score as a novel biomarker for predicting survival in patients with isocitrate dehydrogenase wild-type glioblastoma treated with the Stupp protocolAsim Armagan Aydin, Ahmet Unlu, Neslihan Atabek, et al.Medical Oncology (Northwood, London, England)|October 6, 2007
Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancerEmel Yaman, Aytug Uner, Ozlem Er, et al.Pageof 8